Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy

Madeline M. Cook, Luai Al Rabadi, Andy J. Kaempf, Megan M. Saraceni, Michael A. Savin, Zahi I. Mitri

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences